More on PPBT

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (7/30/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Purple Biotech Ltd. (NQ:PPBT)
Delayed: 1.70 -0.06 (3.41%)
Prev. Close $1.76  
Open$1.75 
52 Wk High$ 
52 Wk Low$ 
Day High$1.79 
Day Low$1.66 
P/E N/A  
EPS$ 
Volume35,477 

Friends, Peers and Foes (?): LPTX WST (more...)

Jun 11, 2026 07:02 AM Form 6-K PURPLE BIOTECH LTD. For: Jun 11
Jun 11, 2026 07:01 AM Purple Biotech presents IM1240 preclinical data at EACR conference
Jun 11, 2026 07:00 AM Purple Biotech Presents New Preclinical Data at EACR 2026 Highlighting IM1240's Anti-Tumor Activity, Favorable Safety and Pharmacokinetic Profile, and Broad Therapeutic Window
May 20, 2026 05:29 PM Form F-3 PURPLE BIOTECH LTD.
May 15, 2026 07:02 AM Form 6-K PURPLE BIOTECH LTD. For: May 15
May 15, 2026 07:00 AM Purple Biotech Reports First Quarter 2026 Financial Results and Business Highlights
May 13, 2026 04:26 PM Form SCHEDULE 13G/A PURPLE BIOTECH LTD. Filed by: INTRACOASTAL CAPITAL, LLC
Apr 27, 2026 07:15 AM Form 6-K PURPLE BIOTECH LTD. For: Apr 27
Apr 27, 2026 07:03 AM Purple Biotech reports preclinical data for IM1240 cancer treatment
Apr 27, 2026 07:00 AM Purple Biotech Announces New Data from CAPTN-3 Platform Tri-specific IM1240
View All Articles

Entities mentioned with PPBT

View All Entities